UHS Is Down 27%. Here is What History Suggests Now

UHS Is Down 27% in 254 Days. Here's What History Suggests

Universal Health Services, Inc. (UHS) is now down 27% from its all-time high as of August 21, 2026, having just exited the red zone after 254 days in drawdown. The Drawdown Severity Score™ has improved to 4.9, placing it in the Significant severity level. In the 16 comparable prior drops of 25% or more, the stock took an average of 679 days to fully recover.

What Caused the Recovery From the Red Zone?

The primary catalyst for the stock's recent recovery from the red zone is a combination of strong earnings performance and strategic expansion. According to Eastern Progress, Universal Health Services reported Q2 earnings and revenues that topped analyst estimates, driven by steady demand across its acute care and behavioral health facilities. This operational strength was further bolstered by major corporate developments.

Healthcare Dive reported that the company closed its $835 million acquisition of Talkspace, a move widely described as a game changer for its digital behavioral health footprint. This acquisition allows the company to integrate virtual therapy into its existing physical network, addressing a key growth area in the healthcare sector.

Additionally, Breakout Stock Alerts noted that steady hospital sector fundamentals have provided a supportive backdrop for the industry. While the stock faced intense selling pressure earlier in the year, these fundamental drivers have helped stabilize the asset, allowing its severity score to climb out of the high-risk red zone.

The Journey: How Deep the Drawdown Went

Before the current correction began, UHS reached an all-time high of $243.98. Over the subsequent 254 days, a combination of shifting market sentiment and macroeconomic pressures dragged the stock down to its current price of $177.26. This represents a total decline of -27.3% from its peak, a move that triggered a prolonged period in the red zone.

Our data shows that this sell-off is far more severe than the typical pullback for this stock. Historically, UHS experiences an average max drawdown of -6.8% with an average drawdown duration of 69 days. The current 254-day stretch highlights a deep and prolonged correction that has tested long-term support levels.

Recovery By the Numbers: Current Severity and Valuation Context

As of August 21, 2026, the Drawdown Severity Score™ for UHS stands at 4.9. This score designates the stock's status as Significant, which corresponds to the yellow zone. While this transition represents a clear improvement from the red zone, the stock still remains 27.3% below its historical peak.

To put this price recovery in perspective, we can look at the company's valuation metrics relative to its historical trading patterns. As of the valuation snapshot date of 2026-08-20, the Price-to-Sales ratio (P/S) for UHS sits at 0.57, which is in the 13th percentile of its own daily P/S record since 2006-08-21, well below its historical median of 0.84. Similarly, its EV-to-EBITDA ratio (EV/EBITDA) is 5.7, placing it in the 7th percentile of its own daily EV/EBITDA history since 2006-08-21, compared to its historical median of 8.2. This indicates that while the stock price has fallen 27.3%, its valuation multiples are also trading near the bottom of their historical ranges relative to the company's own past performance.

Historical Context: How Past Recoveries Played Out

To understand what this transition out of the red zone means, we must look at historical cycles. Over its entire trading history, UHS has logged 204 total historical drawdown events. The vast majority of these were minor pullbacks that resolved quickly.

However, deep drawdowns of 25% or more are relatively rare for this asset. Our data shows that UHS has dropped by 25% or more only 16 times in its history. When the stock experiences a drop of this magnitude, the recovery process is typically measured in years rather than weeks.

The average duration of these comparable 25%+ drops is 679 days. This historical average suggests that while the transition to the yellow zone is a positive signal, investors should expect a lengthy path to a full recovery.

Is It Over? Analyzing the Likelihood of Further Recovery vs. Retest

Exiting the red zone is an important milestone, but it does not guarantee an immediate upward trajectory. Historically, stocks that enter the yellow zone with a Drawdown Severity Score™ of 4.9 often experience periods of consolidation.

According to MarketBeat, Royal Bank of Canada recently reiterated its "Sector Perform" rating for UHS, reflecting a neutral outlook from institutional analysts. Simply Wall St also noted that while the stock looks inexpensive based on earnings, its return metrics remain weaker than in previous expansion cycles. These external assessments align with our data, which shows that a full recovery to previous highs has historically required substantial time.

The stock must maintain its current support levels to avoid slipping back into the red zone. A retest of the recent lows remains a possibility if broader market conditions deteriorate or if hospital sector fundamentals weaken.

Key Levels: Specific Severity and Price Thresholds to Monitor

Investors tracking UHS should focus on several key price levels that correspond to critical shifts in the Drawdown Severity Score™.

To completely clear the Significant severity level and move into the moderate or low risk zones, the stock needs to reclaim higher price targets. Specifically, reducing the drawdown to under 20% would require a price point of approximately $195.18.

Conversely, if the stock faces renewed selling pressure and falls back toward its recent lows, a drop below $170.00 would likely push the severity score back into the red zone. Monitoring these specific thresholds allows market participants to assess the ongoing health of the recovery without relying on emotional market sentiment.